21 CFR 211 PREAMBLE
Detailed guidance document from FDA and regulatory agencies.
Document Details
Preamble
September 29, 1978
c840be82-c9e9-4a22-8eee-ecd5df9dce86
Related Documents
E22 General Considerations for Patient Preference Studies
PreambleFebruary 6, 2026Center for Drug Evaluation and Research
M15 General Principles for Model-Informed Drug Development
PreambleDecember 30, 2024Center for Drug Evaluation and Research
M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines
PreambleJuly 5, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.